NCT/Study#

KB-ENTO-3001

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Entospletinib in Combination With Intensive Induction and Consolidation Chemotherapy in Adults With ACTIVEly Diagnosed Nucleophosmin 1-mutated (NPM1) Acute Myeloid Leukemia

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Entospletinib in Combination With Intensive Induction and Consolidation Chemotherapy in Adults With ACTIVEly Diagnosed Nucleophosmin 1-mutated (NPM1) Acute Myeloid Leukemia

DISEASE GROUP:
Leukemia
current phase:
Phase III
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: